| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099312 | Journal of Crohn's and Colitis | 2014 | 8 Pages |
Abstract
Mycophenolate mofetil may represent a promising treatment for inducing and maintaining remission in IBD patients intolerant of thiopurines. It may be of more value and relevance in ulcerative colitis, since less alternative proven therapies are available.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Matthew R. Smith, Sheldon C. Cooper,